Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has issued an announcement.
ASKA Pharmaceutical Holdings Co., Ltd. has reiterated its request to Dalton Investments and others to provide necessary information regarding their large-scale purchase of ASKA’s share certificates. Despite guidelines emphasizing transparency in corporate takeovers, Dalton has not complied, leading to concerns about the impact on shareholder decision-making and the company’s strategic options.
The most recent analyst rating on (JP:4886) stock is a Buy with a Yen2732.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is based in Tokyo and is involved in the large-scale purchase of company share certificates.
Average Trading Volume: 62,719
Technical Sentiment Signal: Buy
Current Market Cap: Yen64.08B
See more insights into 4886 stock on TipRanks’ Stock Analysis page.